Table 3:
Disease | ORR (%) | CR/CRi for AML (%) CR/mCR for MDS (%) |
Median OS (mos, 95% CI) |
---|---|---|---|
AML | |||
Induction chemotherapy (n=20 pts) | 9 (45.0%) | 9 (45.0%) | 8.8 (1.9–15.5) |
LIT (HMA-based regimens, LDAC) [n=14 pts] | 2 (14.3%) | 2 (14.3%) | 9.4 (1.8–13.6) |
MDS | |||
HMA-based regimens [n=19 pts] | 7 (36.8%) | 6 (31.6%) | 12.1 (5.8-not reached) |